Northeast Pharmaceutical Group (SHE:000597) agreed to purchase a 70% stake in Dingcheng Peptide Source for 186.8 million yuan.
Dingcheng Peptide Source provides technical services for biology and medicine and sells biological reagents, according to a Wednesday filing with the Shenzhen bourse.
Shares of the pharmaceutical company rose 10% in recent trade.